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Abstract
Background: Steroids are often combined with local anesthetic (LA) and injected to reduce pain associated with
various chronic non-cancer pain (CNCP) complaints. The biological rationale behind injection of a steroid solution is
unclear, and it is uncertain whether the addition of steroids offers any additional benefits over injection of LA alone.
We propose to conduct a systematic review and meta-analysis to summarize the evidence for using steroids and
LA vs. LA alone in the treatment of CNCP.
Methods: An experienced librarian will perform a comprehensive search of EMBASE, MEDLINE, and the Cochrane
Central Registry of Controlled Trials (CENTRAL) databases with search terms for clinical indications, LA, and steroid
agents. We will review bibliographies of all relevant published reviews in the last 5 years for additional studies.
Eligible trials will be published in English and randomly allocate patients with CNCP to treatment with steroid and
LA injection therapy or injection with LA alone. We will use the guidelines published by the Initiative on Methods,
Measurement, and Pain Assessment in Clinical Trials (IMMPACT) to inform the outcomes that we collect and
present. Teams of reviewers will independently and in duplicate assess trial eligibility, abstract data, and assess risk
of bias among eligible trials. We will prioritize intention to treat analysis and, when possible, pool outcomes across
trials using random effects models. We will report our findings as risk differences, weighted mean differences, or
standardized mean differences for individual outcomes. Further, to ensure interpretability of our results, we will
present risk differences and measures of relative effect for pain reduction based on anchor-based minimally
important clinical differences. We will conduct a priori defined subgroup analyses and use the Grading of
Recommendations Assessment, Development, and Evaluation (GRADE) system to evaluate the certainty of the
evidence on an outcome-by-outcome basis.
Discussion: Our review will evaluate both the effectiveness and the adverse events associated with steroid plus LA
vs. LA alone for CNCP, evaluate the quality of the evidence using the GRADE approach, and prioritize patient-
important outcomes guided by IMMPACT recommendations. Our results will facilitate evidence-based management
of patients with chronic non-cancer pain and identify key areas for future research.
Trial registration: PROSPERO CRD42015020614
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Background
Burden of the problem
Chronic non-cancer pain (CNCP), defined as pain
persisting beyond the period of normal healing (typic-
ally ≥3 months), is commonly experienced by a large
proportion of adult population. In the USA, according
to 2008 estimates, approximately 100 million adults
were affected by CNCP with associated treatment
costs ranging from $560 to $635 billion (US). This is
greater than annual treatment costs of heart disease,
cancer, or diabetes [1]. In the UK, 53 % of seniors re-
ported that CNCP was the most important factor
impacting their quality of life [2]. Chronic low back
pain (CLBP) has been noted to be the leading cause
of years lived with disability, with neck pain as the
fourth common cause [3]. CNCP accounts for a large
number of physician encounters in the elderly and
aging population. In the USA alone, the proportion of
CLBP patients requesting care from a health provider
increased from 73.1 to 84.0 %, between 1992 and
2006 [4]. Conditions characterized or defined by the
presence of pain accounted for five of the leading ten
conditions associated with the most years lived with
disability [5]. Common peripheral (non-axial) CNCP
conditions include pain in upper or lower limbs, knee
and shoulder joints, headache, carpal tunnel syn-
drome, epicondylitis, fascitis and others.
Treatment considerations
A clear understanding of the underlying pathogenesis of
CNCP is important to drive treatment decisions; how-
ever, despite decades of research, the mechanisms
underlying most CNCP conditions are unclear [5].
CNCP conditions involve a complex interplay of active
pain pathways leading to sensory signaling, along with
peripheral and central sensitization as a result of ner-
vous system changes induced by temporary and long-
term neuroplasticity. Changes resulting from sensitization
lead to modulation of pain signals, which vary from pa-
tient to patient. Most CNCP conditions do not have de-
finitive treatment, and physicians have limited options for
symptomatic management. Analgesic medications are not
always effective and need to be given on a daily basis; they
also involve a risk of drug interaction especially in the eld-
erly adult population. Corticosteroid injections (CSI) are
commonly used to manage many CNCP conditions, des-
pite variability in their clinical presentation and underlying
pathophysiology. For neuraxial pain, epidural steroid in-
jections (ESI) are the most commonly performed inter-
ventions, and in the USA alone, the number of ESIs
administered to Medicare recipients essentially doubled
between 2000 and 2004 (from 740,845 to 1,437,962 proce-
dures/year) [6]. CSIs are also widely used as injections to
knee [7], shoulder [8], carpal tunnel [9], nerve blocks for
occipital nerve [10], suprascapular nerve [11], tendinous
injections for medial and lateral epicondyle [12], and even
for simple trigger point injections [13].
Percutaneous injections using steroids and local
anesthetics
The rationale for injecting local anesthetics (LA) is to
block sensory signals from the region being injected. Al-
though often used for diagnosis—because it should only
lead to a temporary blockade—an injection of LA has
the potential to decrease sensitization, which is a feature
of chronic or persistent pain, thereby possibly prolong-
ing the treatment effect of LA beyond its pharmaco-
logical duration of action [14]. Historically, many
investigators have published on the successful use of epi-
dural injections of saline and LA. Cathelin. F, Pasquier
and Leri, and Sicard published reports as early as 1901
[15]. Later, Evans (1931) published a successful report
using procaine and saline in 22 of 40 patients [16].
Cyriax published multiple manuscripts referring to safe
use of epidural injections using only LA and steroids in
more than 20,000 cases [17, 18]. In fact, up until the
1950s, the injectate used for epidural injections in sciat-
ica consisted of LA and saline. The first recorded use of
steroids in epidural space was by Lievre et al. in 1953
[19]. Discovered by Philip Hench in the 1940s [20], glu-
cocorticoids are potent anti-inflammatory agents. Since
then, steroids have been injected for nearly every chronic
pain indication [21]. In clinical practice, steroids are typ-
ically combined with LA, with or without saline [15].
This practice stems from the hope that the addition of
steroid can lengthen the treatment effect [22]. For most
CNCP conditions (except for evidently inflammatory
conditions such as rheumatoid arthritis), there is no evi-
dence that CSI are disease-modifying agents [23].
Whether steroids have any direct effect on pain gener-
ation or transmission is not clear. There is some experi-
mental evidence demonstrating suppression of ectopic
discharge in neuromas [24]. Pre-clinical experiments
suggest that steroids may reduce neuropathic pain; how-
ever, a paradoxical effect of increased pain in some pa-
tients has also been shown [25]. Surprisingly, there are
few clinical studies that have attempted to elicit the
mechanism behind steroid’s effect on chronic pain other
than as an anti-inflammatory [26]. Thus, the use of ster-
oid for interventions in CNCP lacks clear rationale.
Harms of steroid injections
Corticosteroids can have systemic and local adverse ef-
fects. Systemic side effects are largely dependent upon
the patient’s physiology, injected dose, and systemic ab-
sorption. Theoretically, these systemic effects can occur
when the dose of steroids injected exceeds the rate of
endogenous steroid production of about 20 mg per day
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of hydrocortisone or its equivalent and potentially cause
suppression of pituitary adrenal axis, hypercorticism,
Cushing’s syndrome, osteoporosis, avascular necrosis of
bone, steroid myopathy, weight gain, fluid retention, and
hyperglycemia [21]. Although these risks are unlikely
with a single injection, in clinical practice most patients
receive multiple CSI injections at frequent intervals, and
it is not uncommon for patients to suffer from multiple
chronic pain conditions treated with steroid injections
by different physicians, without necessarily accounting
for the systemic effects of steroid injected elsewhere.
Local adverse effects include soft tissue atrophy, depig-
mentation [27], and alopecia [28]. Beyond the above
recognized adverse effects, the neuraxial steroid injec-
tions (epidural, facet joint) risk causing rare, but cata-
strophic neurologic injuries such as stroke and spinal
cord injury [29].
Limitations of previous reviews
Existing systematic reviews of injection therapy for
CNCP conditions have not specifically compared LA vs.
LA and steroid injections. Further, some reviews have
considered LA injection to be a neutral agent, and com-
bined this intervention with other biologically inactive
control agents such as saline injections [12, 30]. More
recently, within the last quarter of 2015, two additional
reviews have been published. Manchikanti et al.
reviewed all spinal injections targeted at epidural, facet
joint/nerve, and disc pain conditions. Due to the existing
heterogeneity, a meta-analysis was not considered feas-
ible. All RCTs using an active control design were in-
cluded. They observed that LA alone was as equally
effective as LA with steroid, except in disc herniations
[18]. The review by Chou et al. also focussed only on
epidural injections for radiculopathy and spinal stenosis,
without any restriction for the agent used and duration
of chronic pain. They combined LA along with saline as
placebo comparator. Their results showed a small effect
favoring the use of steroids only in radiculopathy for
short-term reduction in pain and function [31]. To illus-
trate these issues, we reviewed the systematic reviews
published in English within the last 5 years, focusing on
injection therapies using CSI for CNCP conditions. We
identified the findings and limitations of those reviews,
apart from identifying whether they included trials that
addressed our review question of comparing LA and
steroid with LA alone for CNCP (Table 1). Twenty seven
out of forty-two reviews included trials comparing LA
and steroid with LA alone [6, 12, 18, 30–53], but only
some reviews have made clear observations on the com-
parison between LA vs. LA and steroid [18, 33, 38, 41,
45, 48, 51]. Very few conducted meta-analyses [12, 31–
33, 35, 39, 41, 45, 48, 51]. The question of whether the
injected steroid has any clinical benefit beyond that
achieved from LA alone is an area of active debate, as
existing studies across various clinical categories have
shown equivalent effects comparing LA and steroid vs.
only LA [54–57]. Findings from our review will help in-
form physicians, healthcare providers, and CNCP pa-
tients on whether the addition of steroid gives any
meaningful benefit to LA injection alone.
Objectives
Our primary objective is to perform a systematic review
and meta-analysis to assess the effectiveness of steroid +
LA injections compared to LA injections, for pain relief
among CNCP patients. Secondary objectives of our re-
view are
 To assess the effect of steroid + LA injections
compared to LA injections alone on the duration of
effect of pain relief.
 To assess the effect of steroid + LA injections
compared to LA injections alone on six core
domains, described as core outcome measures by
the Initiative on Methods, Measurement, and Pain
Assessment in Clinical Trials (IMMPACT) [58]. The
domains other than reduction of pain include
physical functioning; emotional functioning;
participant ratings of global improvement and
satisfaction with treatment, symptoms and adverse
effects, and participant disposition.
Study question
Among adults with CNCP, does LA with corticosteroid
injection (with or without saline) offer better pain relief
when compared to injection with LA alone (with or
without saline), as assessed at a time closest to 4 weeks
after treatment?
Methods
Our review protocol has been registered with PROSPERO
(registration number PROSPERO 2015:CRD420150206
14). This protocol has been prepared for publication ac-
cording to PRISMA-P guidelines [59].
Eligibility criteria
Participants
We will include adult (≥18 years of age) patients with
CNCP, and exclude patients with a known inflammatory
cause of pain such as rheumatoid arthritis, ankylosing
spondylitis, systemic lupus erythematosus and gouty
arthritis, and pain of generalized nature such as fibro-
myalgia or chronic fatigue syndrome. If a trial involves a
mix of cancer and CNCP, or adult and pediatric patients,
we will include the study only if they report outcomes
separately for our study population of interest, or if at
least 90 % of the trial patients are >18 years with CNCP.
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Table 1 Limitations of existing reviews identified by a systematic search of literature
Serial
No
Main Objective Relevant Findings and Limitations Studies relevant to our Review
1 A systematic review and meta-analysis
of RCTs evaluating the "control"
injections in epidural injections for
spinal pain [35].
FINDINGS: As control injections, epidural
non-steroid injections may provide some
benefit, but were inferior to ESI, but
superior to non-epidural injections.
Anderberg 2007 [80];
Beliveau 1971[81]; Brevik 1996 [82];




2011 [88], 2012abcd [89–92];
Nam & Park 2011 [93]; Ng 2005 [94];
Rogers 1992 [95]; Sayegh 2009 [96];
Tafazal 2009 [97]
LIMITATIONS: All LA and saline
comparators were grouped as epidural
non-steroid agents.
2 To assess comparative effectiveness
studies in ESI for Lumbar Spinal
Stenosis and to estimate
reimbursement amounts [37].
FINDINGS: Both, ESIs or LA epidural
injections alone, resulted in better
short term improvement (pain and
walking distance); no longer term
difference.
Fukusaki-1998 [98]; Cuckler 1985 [84];
El Zahaar 1991 [99]
LIMITATIONS: Included both RCTs and
OSs; no metaanalysis.
3 Effectiveness of cervical epidural
injections in the management of
chronic neck and upper
extremity pain [38].
FINDINGS: Similar effectiveness with both
LA only and LA+ steroid injections, except
for slightly better results with radiculitis
from disc herniations
4 by Manchikanti: 2010 [100];
2012a; 2012b; 2012c [101–103]
LIMITATIONS: Included RCTs had differences
in the injectate used with intervention and
control arms; no metaanalysis.
5 Effectiveness and risks of
image guided cervical TFESI [30].
FINDINGS: Limited evidence exists and no
conclusion on effectiveness and risks can
be observed.
Anderberg 2007 [80]
LIMITATIONS: Included three RCTs, only one
of which compared LA+ steroid with
LA only
6 Role of ESIs in the prevention of
surgery for spinal pain [36].
FINDINGS: ESIs may provide a small
surgery-sparing effect in the short term
compared with control injections.
Hegihara 2008 [104]; Klenerman 1984 [86];
Cohen 2012 [83]; Cuckler 1985 [84];
Ghahreman 2010 [85]; Riew 2000 [105];
Sayegh 2009 [96]; Tafazal 2009 [97];
LIMITATIONS: Looked only at
surgery sparing effects; no metaanalysis
7 ESIs in the management of
sciatica [6].
FINDINGS: Small short term benefit in pain
control with ESIs.
Manchikanti 2010a,b; Ghahreman 2010 [85];
Tafazal 2009 [97]; Ng 2005 [94];
Rogers 1992 [95]; Cuckler 1985 [84];
Klenerman 1984 [86]; Swerdlow 1970 [106]LIMITATIONS: No differentiation was made
with the injectate used in control and
treatment arm. Could not incorporate
dichotomous outcome measures into
pooling.
8 The effectiveness of lumbar interlaminar
ESIs in managing chronic low back and
lower extremity pain [33].
FINDINGS: Similar results with both LA only
and LA+ steroid injections, except for
slightly better results with radiculitis from
disc herniations.
Manchikanti 2010a,b [107, 108];
Cuckler 1985; Rogers 1992
LIMITATIONS: Included both RCTs and OSs
without any pooling.
9 Predicting ESIs with lab markers
and imaging techniques [68].
LIMITATIONS: Only aimed at prognostic
accuracy of certain predictive methods
used to determine ESI outcomes.
None
10 A systematic evaluation of thoracic
ESIs [34].
FINDING: The single RCT showed similar
effectiveness with LA or LA +steroid.
Manchikanti. 2010 [109]
LIMITATIONS: Only one RCT, and one OS
were included
11 Effectiveness of TFESI for lumbar
radiculopathy [39].
FINDINGS: Small improvement with steroids
in pain only (short term); long term follow
up showed no difference with steroids.
Riew 2000 [105]; Ng 2005 [94];
Tafazal 2009 [97]
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Table 1 Limitations of existing reviews identified by a systematic search of literature (Continued)
LIMITATIONS: Included only five RCTs, and
for pooling control groups included both
LA and Saline; outcomes as SMD
12 Evaluation of therapeutic lumbar
TFESIs [42].
FINDINGS: Lack of evidence Riew 2000 [105]; Riew 2006 [110]
LIMITATIONS: Only four RCTs; no
metaanalysis; comparators varied in each
study
13 Efficacy of lumbosacral TFESIs: a
systematic review [49].
FINDINGS: Fair evidence supporting TFESIs
as superior to placebo for treating radicular
symptoms.
Riew 2000 [105]; Ng 2005 [94]
LIMITATIONS: Evaluation specific to TFESI;
no metaanalysis; varied comparators.
14 Evaluation of perineural steroids for
trauma and compression-related
peripheral neuropathic pain [41].
FINDINGS: At 1–3 months post-interventions,
steroid group reported lower pain scores than
those who received LA or conventional care.
Karakadas 2011, 2012 [111, 112];
Eker 2012 [113]; Thomson 2013 [114]
LIMITATIONS: Review limited to compression
neuropathies; comparators for pooling
included no injection, or LA, or placebo
(saline).
16 Evaluation of PNBs and TPIs in
headache [40].
FINDINGS: Lack of studies and inherent
limitations within the included studies.
Ashkenazi 2008 [115]
LIMITATIONS: Did not identify any study on
TPI; both RCTs and non-RCTS were included;
no assessment of risk; no metaanalysis.
17 Treatment of carpal tunnel
syndrome [43].
FINDINGS: Local steroid injection is
recommended before surgery.
Armstrong 2004 [116]
LIMITATIONS: A report as guidelines for
management based on previous systematic
reviews; however no differentiation
between steroids with or without LA.
18 Neural blockade for persistent pain
after breast cancer surgery [69].
FINDINGS: Lack of evidence. None
LIMITATIONS: Only two RCTs on stellate
ganglion block.
19 Occipital nerve blocks: when and
what to inject [52].
LIMITATIONS: Narrative review with search
obtained from google scholar and MD
consult
Afridi 2006 [117]; Ambrosini 2005 [118];
Ashkenazi 2008 [115]
20 IA infiltration therapy for patients
with glenohumeral osteoarthritis [70].
FINDINGS: No clear conclusions on the
use of IA steroid due to lack of evidence.
None
LIMITATIONS: Studies of all kinds of injection
treatments; only two RCTs of IA injection
involving hyaluronic acid.
21 A metaanalysis of steroid injections
for painful shoulder [32].
FINDINGS: Subacromial injections of steroids
are effective for improvement for rotator
cuff tendonitis, and are better than NSAIDS
and placebo injections.
Blair 1996 [119]; Plafki 2000 [120];
Vecchio 1993 [121]
LIMITATIONS: Out of five RCTs included
for pooling only three compared
LA + steroid vs LA; results not
considered separately.
22 Review of glenohumeral steroid
injections in adhesive capsulitis [71].
FINDINGS: Steroids injections offer good
short-term outcomes when compared
to physical therapy and other treatments.
None
LIMITATIONS: Although 16 RCTs were
included, none of them compared
LA + steroid with only LA.
23 Assessment of Subacromial steroid
injections in the treatment of
rotator cuff disease [44].
FINDINGS: Little reproducible evidence
to support the efficacy of subacromial
Akgun 2004 [122]; Alvarez 2005 [123];
Blair 1996 [119]; Petri 1987 [124]; Withrington 1985 [125]
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Table 1 Limitations of existing reviews identified by a systematic search of literature (Continued)
steroid injections in managing rotator
cuff disease.
LIMITATIONS: Out of nine RCTs, three
involved patients with acute pain; no
metaanalysis; varying comparators
within the studies.
24 IA cortisone injection for osteoarthritis
of the hip. Is it effective and safe [46]?
FINDINGS: Lack of clear evidence; steroid
injections are better in refractory pain; of
the four RCTs- two of the trials showed
opposite results with LA vs LA + steroid
Lambert 2007 [126]; Flanagan 1988 [128]
LIMITATIONS: Identified only four RCTs;
no metaanalysis.
25 Is anesthetic Hip Joint Injection Useful
in Diagnosing Hip Osteoarthritis? A
Meta-Analysis of Case Series [72].
LIMITATIONS: Only non-RCTs, and does
not allow for clear conclusions or
directions.
None
26 Injection therapies in LE: a systematic
review and network meta-analysis
of RCTs [45].
FINDINGS: No statistically significant
difference in benefit compared with
placebo for steroid injections.LIMITATIONS:
Network meta-analysis involving 10 trials
of steroid injections; LA was not considered




Price 1991a,b [131, 132]
27 Treating LE with steroid injections
or physiotherapy: a systematic
review [48].
FINDINGS: For steroid vs LA injection,
the evidence is conflicting; steroid
injections have a short term beneficial
effect, but a negative effect in the
intermediate term.
Lindenhovious 2008 [129];
Newcomer 2001 [130]; Price 1991 [131]
LIMITATIONS: Outcomes pooled
separately, and expressed as SMD for
continuous and RD for dichotomous
28 To assess the effectiveness of
interventions for cubital tunnel
syndrome, radial tunnel syndrome,
instability, or bursitis of the elbow:
a systematic review [73].
FINDINGS: No or limited evidence
found for the effectiveness of
nonsurgical and surgical interventions;
lack of good controlled studies.
None
LIMITATIONS: Various interventions with
varying comparators; no studies relevant
to LA vs LA +steroid; no metaanalysis.
30 To evaluate the effectiveness of
corticosteroid injections for lateral
epicondylitis [51].
FINDINGS: For studies (3) comparing LA
vs steroid, beneficial effects were found
favoring steroid injections.
Price 1991 [131]
LIMITATIONS: Out of 15 RCTs, five
compared LA with LA and steroid.
Outcomes with various comparators
pooled together.
31 Non-surgical treatment of LE: a
systematic review of RCTs [50].
FINDINGS: Existing literature does not
provide conclusive evidence for a







treatments were considered together; no
metaanalysis
32 Assessing the efficacy and safety of
steroid injections and other
injections for management of
tendinopathy [12].
FINDINGS: For LE: Steroid injections
reduced pain in the short term; but studies
comparing only LA showed conflicting
results; rotator tendinopathy results are
conflicting; Achilles and Patellar
tendinopathies-no studies of comparison;
ME-no benefit from steroid injection.
LE: Lindenhovious 2008 [129];
Newcomer 2001 [130]; Price 1991 [131]
ME: Stahl 1997 [134]
LIMITATIONS: The effect of steroid
injections were compared using all
comparators; no separate analysis with
LA + steroid vs only LA.
RT: Adebajo 1990 [135]; Alvarez 2005 [123];
Blair 1996 [119]; Ekeberg 2009 [136];
Mclnerney 2003 [137]
Shanthanna et al. Systematic Reviews  (2016) 5:18 Page 6 of 14
Table 1 Limitations of existing reviews identified by a systematic search of literature (Continued)
33 Evaluation of minimally invasive
therapies in the management of
chronic calcific tendinopathy of
the rotator cuff. [74].
FINDINGS: Lack of evidence. None
LIMITATIONS: Did not identify any studies
comparing steroid injection with LA.
34 Efficacy of treatment of trochanteric
bursitis: a systematic review [75].
FINDINGS: Lack of evidence. None
LIMITATIONS: Only one RCT for steroid
injection assessing image guidance.
35 Evaluation of non-operative
management of discogenic
back pain [76].
FINDINGS: Lack of evidence. None
LIMITATIONS: Identified only two RCTs
performing intradiscal steroid injections;
no study compared LA + steroid vs LA
36 Evaluation of various modes of
diagnosis and treatment of
suspected discogenic pain [77].
FINDINGS: There is lack of diagnostic
criteria and lack of studies with uniform
treatment strategies.
None
LIMITATIONS: Did not identify any
suitable RCTs.
37 Evaluation of therapeutic thoracic
facet joint interventions [47].
FINDINGS: Paucity of evidence, but one
trial showed no difference between
LA+ steroid vs LA.
Manchikanti 2012 [138]
LIMITATIONS: Identified only one RCT on
nerve block; no study on joint injections
38 Effectiveness of therapeutic
lumbar facet joint
interventions [53].
FINDINGS: Paucity of evidence, but one
trial showed no difference between
LA+ steroid vs LA.
Manchikanti 2001 [139]
LIMITATIONS: Identified only one RCT on
nerve block; no study on joint injections.
39 Emerging concepts in the
treatment of myofascial pain:
a review of medications,
modalities, and needle-based
interventions [78].
FINDINGS: There is insufficient evidence
for both medications and needle based
interventions for myofascial pain.
None
LIMITATIONS: Did not identify any RCT
comparing LA + steroid vs LA.
40 To assess the efficacy and safety
of using TPI to treat patients
with chronic non-malignant
musculoskeletal pain [79].
FINDINGS: No clear evidence to support
the use of TPI.
None
LIMITATIONS: Did not identify any RCT
comparing LA + steroid vs LA.
41 To compare the efficacy of saline,
LA, and steroids in epidural and
facet joint injections for the
management of spinal pain [18].
FINDINGS: LA with steroids and LA alone
were equally effective except in disc
herniation, where the superiority of LA
with steroids was demonstrated over LA alone.
Anderberg 2007 [80]; Beliveau 1971 [81];
Brevik 1996 [82]; Cohen 2012 [83];
Cuckler 1985 [84]; Ghahreman 2010 [85];
Klenerman 1984 [86]; Manchikanti 2008 [87],
2011 [88], 2012abcd [89–92];
Nam & Park 2011 [93];
Ng 2005 [94]; Rogers 1992 [95];
Sayegh 2009 [96]; Tafazal 2009 [97]
LIMITATIONS: RCTs involving the
injections of sodium chloride solution
was also included as active comparator,
along with LA alone injections.
Studies were not excluded based on
the duration of chronic pain.
No metaanalysis was done.
42 To assess the benefits and harms
of ESIs in adults with radicular
low back pain or spinal stenosis
of any duration [31].
FINDINGS: For radiculopathy, small effect
favoring the use of steroids for short term
reduction in pain and function.
No evidence of benefit in spinal stenosis.
Anderberg 2007 [80]; Beliveau 1971 [81];
Brevik 1996 [82]; Cohen 2012 [83];
Cuckler 1985 [84]; Ghahreman 2010 [85];
Klenerman 1984 [86]
LIMTATIONS: Combined all non-steroid
agents as placebo comparators.
Focused on radicular pain, but included
studies of any duration.
Abbreviations: LA local anesthetic; RCT randomized control trial; OS observational study; ESI epidural steroid injection; TFESI transforaminal epidural steroid
injection; SMD standard mean deviation; PNB peripheral nerve block; TPI trigger point injection; LE lateral epicondylitis; ME medial epicondylitis; RD risk difference;
IA intra-articular injection
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Studies
Parallel design, randomized controlled trials (RCTs) will
be eligible for our review. We will exclude trials with
crossover design, N of 1 trials, and non-therapeutic trials.
Interventions
Eligible studies must randomize patients to receive LA +
steroid or LA only, with or without saline, administered as
percutaneous injection. We will exclude trials in which in-
jections involve any additional agent (e.g., Hyaluronidase,
dextrose, plasma), and any injection which involves a co-
interventional procedure (e.g., radiofrequency treatment,
epidurolysis).
Information sources
We will search the following electronic databases, from
its inception till our search date: EMBASE, MEDLINE,
and the Cochrane Central Registry of Controlled Trials
(CENTRAL). Our search will not be limited to language.
We will record the time and date of the literature
search performed on each database. As a supplemen-
tary search, we will search the WHO clinical trial regis-
try (http://apps.who.int/trialsearch/Default.aspx), and
clinical trial registry (https://clinicaltrials.gov/), to look
for any registered studies, which fulfill our eligibility
criteria, and crosscheck for published results. Unpub-
lished, but completed, study results will be requested
from the authors or investigators. To further ensure
comprehensiveness, we will review the bibliographies of
relevant reviews published in English over the last
5 years (shown in Table 1).
Search strategy
The search will be performed using a sensitive strategy,
prepared by an experienced librarian (RC), for each
specific database, based in part on a comprehensive list
of CNCP indications for which CSI are commonly uti-
lized. The search terms will include possible indica-
tions, along with terms identifying corticosteroids, and
LAs (Additional file 1).
Study records
Data management
We will conduct our review using an online software
tool specially optimized to conduct systematic
reviews—DistillerSR (https://distillercer.com/).
Study screening and selection
Studies fulfilling our eligibility criteria will be selected
through a two-level screening process using standard-
ized forms, applied through DistillerSR. At each stage,
paired reviewers trained in health research methods will
screen for studies for eligibility, independently and in
duplicate. The first level will be done on titles and
available abstracts of identified citations. For citations
judged as potentially eligible, full-text article screening
will be done. To ensure consistency, reviewers will per-
form a calibration exercise, before beginning with
screening. Reviewers will be asked to resolve disagree-
ment by consensus, or if a discrepancy remains, through
discussion with an arbitrator (HS). A quadratic kappa
statistic will be calculated as a measure of inter-observer
agreement, independent of chance regarding study eligi-
bility and interpreted as almost perfect agreement (0.81–
0.99), substantial agreement (0.61–0.80), moderate
agreement (0.41–0.60), fair agreement (0.21–0.40), slight
agreement (0.01–0.20), <0 as less than chance agreement
[60].
Data collection process
Reviewers working in pairs will extract the required data
from each included study using a standardized data ex-
traction form using DistillerSR (https://distillercer.com/).
This form will be piloted between all pairs of reviewers for
consistency and accuracy. To assist with the data extrac-
tion, a detailed instruction manual will be provided along
with each relevant form.
Data items
Data abstracted will include study characteristics includ-
ing risk of bias items, demographic information, partici-
pant flow through the study, and outcomes on
continuous and binary measures captured on six core
domains as recommended by the IMMPACT statement
guidelines [58].
Outcomes and prioritization
We will consider pain relief as our primary outcome.
We will also capture other outcomes (as guided by
IMMPACT) including reporting of adverse effects. We
will also prioritize the use of intention to treat analysis
(ITT). We will only pool data across trials if there are
three or more studies contributing to an outcome do-
main. It is recognized that presentation of relative effects
will facilitate interpretation of treatment effects, and cli-
nicians generally find dichotomous presentation of con-
tinuous outcomes more useful [61]. In the following
section, we will explain the method of analysis as consid-
ered for pain relief. We will perform a similar analysis,
as appropriate, for other IMMPACT outcomes.
Data synthesis and analysis of outcomes
We expect that all included trials will have captured a
measure of pain relief, and this domain could be
expressed in any of the following types: outcomes re-
ported as binary (successful or not successful), outcomes
reported in ordinal categorical scale (mild, moderate and
severe), and outcomes reported in various continuous
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outcome scales. For the primary outcome, we will con-
sider the outcomes reported closest to 4 weeks after the
study interventions. Pain relief measured at this time will
give us indication of treatment efficacy beyond the ef-
fects of placebo. For the primary analysis, we will use a
complete case analysis with ITT. Analysis and synthesis
will be done using revman (review manager) 5.3. Using
random effects model for pooling, we will calculate the
risk ratio (to be interpreted as the risk of having success)
for dichotomous outcomes and weighted mean differ-
ence (WMD) for continuous outcomes converted into
0–10 (11 point) numerical rating scale (NRS) for pain.
Further, we will dichotomize all included patients into
proportion of successful patients for pain relief, to be
able to report risk ratio across all included studies. How-
ever, dichotomising continuous outcomes will result in a
loss of statistical power. Hence, we will also report the
WMD. To achieve this, we will be performing the fol-
lowing methodological steps.
1. Converting outcomes reported in various continuous
scales to a reference instrument scale of 0 to 10 NRS:
According to IMMPACT, the 11-point NRS measure
of pain intensity is recommended as a core outcome
measure in clinical trials of chronic pain treatments.
Furthermore, the 0–10 NRS is preferred over the VAS
(visual analog scale) by patients and clinicians for its
relative simplicity and ease of administration [58].
2. Converting continuous outcomes from 0–10 NRS into
dichotomous data. A reduction of two points on the
0–10 NRS could be considered as the threshold to
establish minimally important difference (MID),
reflecting an average reduction of pain by 30 %
[58, 62]. For studies, which report only end scores,
we will consider a threshold of 4 or less in a 0–10
NRS, to dichotomize the patients. A score of 4 or less
is considered as mild pain [63].
3. Converting categorical measurement results to a
dichotomous data. The categories of ordinal scale
commonly used in pain studies could include mild,
moderate and severe pain. It has been shown that
these categories correspond to the following
thresholds of 0–10 NRS. Mild pain 0–4, moderate
pain 5–7, and severe pain 8–10 [63]. Any change
from a higher ordinal category to a lower ordinal
category would be considered as a successful
outcome for patients reported in a particular study,
allowing us to dichotomize the study outcomes into
success and failures for each arm.
4. Imputation for participants treated as lost to follow
up for continuous and dichotomous outcomes (for
sensitivity analyses). We will consider patient LTFU
subsequent to randomization as missing for data
analysis, and will be explored further for imputation,
if it is >5 %. For trials in which the authors report
total missing participant data only, without
specifying at what stage the participants were
missing, we will consider the total sample size and
the actual sample size included for final analysis and
assume that missing data were equally distributed
between the arms. For trials in which the authors
reported imputed analysis only, we will use the
imputed results for the meta-analysis. We will
perform imputational strategies as described by
Ebrahim et al. [64] and Akl et al. [65], for
continuous measures and dichotomous measures,
respectively.
For secondary outcomes, we will pool the outcomes
for other IMMPACT domains using a random effects
model only if there are three or more studies for a par-
ticular domain. We will report the pooled outcome as
WMD or standardized mean difference (SMD) as
appropriate.
Risk of bias assessment and identification
Each included study will be assessed for risk of bias at
the study level, using the Cochrane risk of bias tool,
based on the components of random sequence gener-
ation, allocation concealment, blinding of participants,
blinding of outcome assessment, incomplete outcome
data, and selective outcome reporting. We will use a
modified Cochrane risk of bias instrument, with re-
sponse options of “definitely yes,” “probably yes,” “prob-
ably no,” and “definitely no.” We will assign trials in the
“definitely yes” and “probably yes” categories a high risk
of bias and those in the “probably no” and “definitely
no” categories a low risk of bias. These items for each
study will be extracted, in duplicate, during the data ex-
traction stage, using the DistillerSR web tool. Any dis-
agreement on the risk of bias item scoring will be noted
and arbitrated by the primary investigator (HS). Agree-
ment on risk of bias scoring will be assessed on a
component-by-component basis, using quadratic
kappa weighting and interpreted as stated before. No
study will be excluded based on its risk of bias. We
will contact study authors if limitations in reporting
lead to uncertainties in eligibility, risk of bias, or
outcome.
Assessment of heterogeneity
Statistical heterogeneity will be calculated using
Cochrane’s Q test, with a threshold of p value at 0.10,
and I2 statistic to describe the percentage variability in
individual effect estimates that could be due to true dif-
ferences between the studies rather than a sampling
error.
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Subgroup and sensitivity analysis to explore
heterogeneity
The following a priori hypotheses would be considered
for subgroup analyses, and as possible reasons for unex-
plained heterogeneity in the pooled estimates. The sub-
group analysis will only be done if there are more than
two studies per subgroup.
1. Clinical category level subgroup analysis. Although,
the underlying rationale that adding steroids to LA
may not provide any meaningful improvement to
pain reduction is consistent across all clinical
indications and trials, there is potential for clinical
heterogeneity in these conditions because of the
variation in underlying pain pathways, pain
sensitization, and hence the possibility of varying
effects of steroids. Considering this, we will perform
subgroup analysis of pain outcomes based on target
structures injected. The seven clinical categories
considered are as follows.
1. Peripheral joint: hip, knee, shoulder joint
injections, and other joint injections.
2. Spinal joint/facet nerve (medial branch block)/
spinal disc: Facet joint or disc injections.
3. Spinal nerve or epidural or intrathecal: Epidural
injections including transforaminal epidural.
4. Peripheral nerve: various nerves including
occipital nerve, suprascapular, and median nerve.
5. Autonomic ganglia: injections to stellate ganglia,
celiac plexus, lumbar sympathetic block.
6. Soft tissue injection: injections for lateral or
medial elbow ligaments, subacromial bursa, or
plantar fascia.
7. Trigger point or intramuscular: injections to
trigger point, piriformis muscle, or any other
intramuscular injections.
2. Larger effects toward steroids could be observed in
studies with components of higher risk of bias; we
will conduct this subgroup analysis on a risk of bias
component-by-component basis, only if there is con-
siderable variability within the risk of bias
component.
3. Sensitivity analysis for LTFU will be conducted as
described previously.
4. Studies which involved treatment interventions as
a series, rather one specific injection (for example,
three steroid injections over 1 month). We
anticipate that the direction of effect would favor
the steroid treatment due to systemic additive
effect.
Addressing potential biases
Publication bias will be assessed using a funnel plot, if
there are more than ten studies included in a meta-
analysis. Further, it will be explored by the test of Egger
[66]. Selective outcome reporting is difficult to identify
when the study protocols are not available or published.
For our review, we will consider the possibility of select-
ive outcome reporting, when the outcomes are described
in the Methods section but not identified or reported in
the results section of the same study report [67].
Interpretation and reporting
We will report our findings as risk ratios, WMD, or
SMD for individual outcomes, along with their 95 %
confidence intervals. Within each clinical category (sub-
groups), similar findings will be reported. We will also
report the outcome for pain relief as a single pooled esti-
mate of risk ratio by dichotomising the continuous out-
comes. This method has been suggested as appropriate
and meaningful for interpretation in systematic reviews
of pain studies [54]. We will also report the findings in
measures of relative risk reduction and absolute risk re-
duction. Rating of quality of evidence will also be done
using the Grading of Recommendations Assessment,
Development, and Evaluation (GRADE) approach. This
will enable us to report our study findings in the form of
“summary of findings” table and allow us to evaluate the
certainty in effect estimates.
Discussion
Despite the several advances in the field of chronic pain,
we still do not fully understand the nature and mecha-
nisms causing CNCP. Although steroids are being used
in nearly every injection or interventional therapy, the
reasons for its use are unclear. Our comprehensive sys-
tematic review will assess the clinical benefits of steroids
when used along with LA, by comparing it with the effects
of LA alone. This evaluation of both the effectiveness and
the adverse events will include patient-important outcomes
as outlined in IMMPACT recommendations, thereby en-
hancing comparability and external validity. Our results
will facilitate evidence-based management of patients
with chronic non-cancer pain and identify key areas for
future research.
The review as such will be limited by the included
studies and their quality. As highlighted above, we will
attempt to decrease the potential for bias by performing
reasonable subgroup and sensitivity analysis, including
imputation for missed outcomes.
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